CSF3 and cancer: In fact, we found that a single dose of 50 μg/mouse sLP given 3 h after 8 Gy TBI was as effective in rescuing C57BL/6 mice as 16 daily post-irradiation injections of recombinant G-CSF (Neupogen®, Amgen, Inc.), the current standard of care for myelosuppression associated with cancer treatment (Figure S2B).